325 related articles for article (PubMed ID: 29501966)
1. Levodopa improves response inhibition and enhances striatal activation in early-stage Parkinson's disease.
Manza P; Schwartz G; Masson M; Kann S; Volkow ND; Li CR; Leung HC
Neurobiol Aging; 2018 Jun; 66():12-22. PubMed ID: 29501966
[TBL] [Abstract][Full Text] [Related]
2. Atomoxetine restores the response inhibition network in Parkinson's disease.
Rae CL; Nombela C; Rodríguez PV; Ye Z; Hughes LE; Jones PS; Ham T; Rittman T; Coyle-Gilchrist I; Regenthal R; Sahakian BJ; Barker RA; Robbins TW; Rowe JB
Brain; 2016 Aug; 139(Pt 8):2235-48. PubMed ID: 27343257
[TBL] [Abstract][Full Text] [Related]
3. Levodopa medication improves incidental sequence learning in Parkinson's disease.
Beigi M; Wilkinson L; Gobet F; Parton A; Jahanshahi M
Neuropsychologia; 2016 Dec; 93(Pt A):53-60. PubMed ID: 27686948
[TBL] [Abstract][Full Text] [Related]
4. Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.
Parkinson Study Group
JAMA; 2000 Oct; 284(15):1931-8. PubMed ID: 11035889
[TBL] [Abstract][Full Text] [Related]
5. Levodopa medication does not influence motor inhibition or conflict resolution in a conditional stop-signal task in Parkinson's disease.
Obeso I; Wilkinson L; Jahanshahi M
Exp Brain Res; 2011 Sep; 213(4):435-45. PubMed ID: 21796541
[TBL] [Abstract][Full Text] [Related]
6. Dopaminergic medication shifts the balance between going and stopping in Parkinson's disease.
Wylie SA; van Wouwe NC; Godfrey SG; Bissett PG; Logan GD; Kanoff KE; Claassen DO; Neimat JS; van den Wildenberg WPM
Neuropsychologia; 2018 Jan; 109():262-269. PubMed ID: 29269306
[TBL] [Abstract][Full Text] [Related]
7. Age at Parkinson's disease onset modulates the effect of levodopa on response inhibition: Support for the dopamine overdose hypothesis from the antisaccade task.
Waldthaler J; Stock L; Krüger-Zechlin C; Timmermann L
Neuropsychologia; 2021 Dec; 163():108082. PubMed ID: 34728241
[TBL] [Abstract][Full Text] [Related]
8. The function of dopaminergic neural signal transmission in auditory pulse perception: evidence from dopaminergic treatment in Parkinson's patients.
Geiser E; Kaelin-Lang A
Behav Brain Res; 2011 Nov; 225(1):270-5. PubMed ID: 21787806
[TBL] [Abstract][Full Text] [Related]
9. Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression.
Parkinson Study Group
JAMA; 2002 Apr; 287(13):1653-61. PubMed ID: 11926889
[TBL] [Abstract][Full Text] [Related]
10. Dopamine depletion impairs gait automaticity by altering cortico-striatal and cerebellar processing in Parkinson's disease.
Gilat M; Bell PT; Ehgoetz Martens KA; Georgiades MJ; Hall JM; Walton CC; Lewis SJG; Shine JM
Neuroimage; 2017 May; 152():207-220. PubMed ID: 28263926
[TBL] [Abstract][Full Text] [Related]
11. Levodopa influences striatal activity but does not affect cortical hyper-activity in Parkinson's disease.
Martinu K; Degroot C; Madjar C; Strafella AP; Monchi O
Eur J Neurosci; 2012 Feb; 35(4):572-83. PubMed ID: 22304628
[TBL] [Abstract][Full Text] [Related]
12. l-Dopa responsiveness is associated with distinctive connectivity patterns in advanced Parkinson's disease.
Akram H; Wu C; Hyam J; Foltynie T; Limousin P; De Vita E; Yousry T; Jahanshahi M; Hariz M; Behrens T; Ashburner J; Zrinzo L
Mov Disord; 2017 Jun; 32(6):874-883. PubMed ID: 28597560
[TBL] [Abstract][Full Text] [Related]
13. Dopaminergic basis for impairments in functional connectivity across subdivisions of the striatum in Parkinson's disease.
Bell PT; Gilat M; O'Callaghan C; Copland DA; Frank MJ; Lewis SJ; Shine JM
Hum Brain Mapp; 2015 Apr; 36(4):1278-91. PubMed ID: 25425542
[TBL] [Abstract][Full Text] [Related]
14. Effects of levodopa on corticostriatal circuits supporting working memory in Parkinson's disease.
Simioni AC; Dagher A; Fellows LK
Cortex; 2017 Aug; 93():193-205. PubMed ID: 28675834
[TBL] [Abstract][Full Text] [Related]
15. Dopamine modulates striatal response to reward and punishment in patients with Parkinson's disease: a pharmacological challenge fMRI study.
Argyelan M; Herzallah M; Sako W; DeLucia I; Sarpal D; Vo A; Fitzpatrick T; Moustafa AA; Eidelberg D; Gluck M
Neuroreport; 2018 May; 29(7):532-540. PubMed ID: 29432300
[TBL] [Abstract][Full Text] [Related]
16. Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET.
Tedroff J; Pedersen M; Aquilonius SM; Hartvig P; Jacobsson G; Långström B
Neurology; 1996 May; 46(5):1430-6. PubMed ID: 8628494
[TBL] [Abstract][Full Text] [Related]
17. Cognitive deficits and striatal dopaminergic denervation in Parkinson's disease: a single photon emission computed tomography study using 123iodine-beta-CIT in patients on and off levodopa.
Duchesne N; Soucy JP; Masson H; Chouinard S; Bédard MA
Clin Neuropharmacol; 2002; 25(4):216-24. PubMed ID: 12151909
[TBL] [Abstract][Full Text] [Related]
18. Brain dopaminergic modulation associated with executive function in Parkinson's disease.
Farid K; Sibon I; Guehl D; Cuny E; Burbaud P; Allard M
Mov Disord; 2009 Oct; 24(13):1962-9. PubMed ID: 19672989
[TBL] [Abstract][Full Text] [Related]
19. The pattern of striatal dopaminergic denervation explains sensorimotor synchronization accuracy in Parkinson's disease.
Miller NS; Kwak Y; Bohnen NI; Müller ML; Dayalu P; Seidler RD
Behav Brain Res; 2013 Nov; 257():100-10. PubMed ID: 24076152
[TBL] [Abstract][Full Text] [Related]
20. The single intake of levodopa modulates implicit learning in drug naïve, de novo patients with idiopathic Parkinson's disease.
Geffe S; Schindlbeck KA; Mehl A; Jende J; Klostermann F; Marzinzik F
J Neural Transm (Vienna); 2016 Jun; 123(6):601-10. PubMed ID: 27106907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
